Global Information
회사소개 | 문의

세계의 미세바늘 약물 전달 시스템 시장(2018년)

Global Microneedle Drug Delivery Systems Market Professional Survey Report 2018

리서치사 QYResearch
발행일 2018년 12월 상품 코드 491481
페이지 정보 영문 147 Pages
가격
US $ 3,500 ₩ 3,961,000 PDF by E-mail (Single User License)
US $ 7,000 ₩ 7,922,000 PDF by E-mail (Enterprise Wide License)


세계의 미세바늘 약물 전달 시스템 시장(2018년) Global Microneedle Drug Delivery Systems Market Professional Survey Report 2018
발행일 : 2018년 12월 페이지 정보 : 영문 147 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

미세바늘은 급성장하고 있는 기술로, 피내 약물 투여를 둘러싼 문제를 해결하기 위해서 개발되었습니다.

세계의 미세바늘 약물 전달 시스템(Microneedle Drug Delivery Systems) 시장에 대해 조사 분석하고, 시장 규모(실적과 예측), 지역별 주요 데이터 등 주요 제조업체에 초점을 맞춘 체계적인 정보를 제공합니다.

제1장 산업 개요

  • 정의
  • 종류별
  • 용도별
  • 지역별
  • 시장 규모
  • 거시지표

제2장 제조비용 구조 분석

  • 원재료와 공급업체
  • 제조비용 구조 분석
  • 제조공정 분석
  • 산업체인 구조

제3장 기술 데이터와 제조 공장 분석

  • 주요 제조업체의 본사와 설립일
  • 제품 종류
  • 임상단계

제4장 전체 시장

  • 3M 제품
  • Qtrypta
  • Soluvia Microinjection System
  • MicronJet600
  • MicroCor
  • h-Patch
  • PASSPORT Transdermal Microporation Technology
  • Microdermics 제품
  • VaxMAT·DrugMAT
  • Nanopatch
  • LTS 제품

제5장 지역별 시장 분석

  • 북미
  • 중국
  • 유럽
  • 동남아시아
  • 일본
  • 인도

제6장 시장 분석 : 종류별

  • Hollow Microneedle Technology
  • Solid Microneedle Technology
  • Dissolving Microneedles Technology

제7장 시장 분석 : 용도별

  • 용도별
  • 연구 상황

제8장 주요 제조업체 분석

  • 3M
  • Zosano Pharma
  • Becton-Dickinson(BD) Technologies
  • Nanopass Technologies
  • Corium
  • Valeritas
  • Nitto
  • Microdermics
  • TheraJect, Inc
  • Vaxxas
  • Lohmann Therapie-Systeme AG

제9장 개발 동향

  • 시장 동향 분석
  • 지역별 시장 동향
  • 시장 동향 : 제품 종류별
  • 시장 동향 : 용도별

제10장 주요 암 분석

  • 대장암
  • 폐암
  • 췌장암
  • 유방암
  • 전립선암
  • 기타

제11장 영향요인

  • 거시경제 요인
  • 원재료 가격 동향
  • 제조원가 구조

제12장 결론

제13장 조사 방법과 데이터 출처

LSH 18.12.28

List of Tables and Figures

  • Figure Picture of Microneedle Drug Delivery Systems 1
  • Figure Global Microneedle Drug Delivery Systems Market Size (M USD) and Growth Rate Comparison by Types (2020-2035) 2
  • Figure Global Microneedle Drug Delivery Systems Market Size Market Share by Types in 2025 3
  • Figure Product Picture of Hollow Microneedle Technology 4
  • Figure Product Picture of Solid Microneedle Technology 4
  • Figure Product Picture of Dissolving Microneedles Technology 5
  • Figure Global Microneedle Drug Delivery Systems Market Size (M USD) Comparison by Applications (2020-2035) 6
  • Figure Global Microneedle Drug Delivery Systems Consumption Market Share by Applications 7
  • Figure Drug Delivery Examples 7
  • Figure Vaccine Delivery Examples 8
  • Figure Global Microneedle Drug Delivery Systems Revenue (M USD) Comparison by Regions (2020-2035) 9
  • Figure North America Microneedle Drug Delivery Systems Revenue (M USD) and Growth Rate (2020-2035) 10
  • Figure China Microneedle Drug Delivery Systems Revenue (M USD) and Growth Rate (2020-2035) 11
  • Figure Europe Microneedle Drug Delivery Systems Revenue (M USD) and Growth Rate (2020-2035) 12
  • Figure Japan Microneedle Drug Delivery Systems Revenue (M USD) and Growth Rate (2020-2035) 13
  • Figure India Microneedle Drug Delivery Systems Revenue (M USD) and Growth Rate (2020-2035) 14
  • Figure Southeast Asia Microneedle Drug Delivery Systems Revenue (M USD) and Growth Rate (2020-2035) 15
  • Figure Global Microneedle Drug Delivery Systems Revenue (M USD) Status and Outlook (2020-2035) 16
  • Figure GDP for Major Regions in 2016 17
  • Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060 18
  • Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016 18
  • Figure Saving Rate Total, % of GDP, 2015 19
  • Figure United States Fed Funds Rate 19
  • Figure China Interest Rate 20
  • Figure Japan Interest Rate 20
  • Figure JPY LIBOR Three-Month Rate 21
  • Figure the United Kingdom Interest Rate 21
  • Figure South Korea Interest Rate 22
  • Figure Forecast of Global Middle-Class Population, 2015 to 2030 23
  • Figure Household Disposable Income Gross adjusted, US dollars/capita, 2016 24
  • Figure Household Spending Total, Million US dollars, 2015 24
  • Figure Net National Income Total, US dollars/capita, 2017 25
  • Figure Price of raw materials in dollars: Evolution 25
  • Table Microneedle Drug Delivery Systems Raw Material and Suppliers 26
  • Figure Manufacturing Cost Structure Analysis of Microneedle Drug Delivery Systems in 2017 27
  • Figure Manufacturing Process Analysis of Microneedle Drug Delivery Systems 28
  • Figure Industry Chain Structure of Microneedle Drug Delivery Systems 29
  • Table Headquarters and Established Date of Global Microneedle Drug Delivery Systems Major Manufacturers 30
  • Table Product Type of Global Microneedle Drug Delivery Systems Major Manufacturers 30
  • Table Clinical Stage of Global Microneedle Drug Delivery Systems Major Manufacturers 31
  • Figure Picture of Solid Microneedle System (sMTS) 33
  • Figure Picture of Hollow Microneedle System (hMTS) 34
  • Figure 3 Simple Application Steps illustrations 37
  • Figure Microstructures Enable Transdermal Delivery of Any Size Molecule 38
  • Figure Picture of PASSPORT Transdermal Microporation Technology 39
  • Figure North America Microneedle Drug Delivery Systems Revenue (M USD) and Growth Rate (2020-2035) 44
  • Figure North America Biologics and Biosimilars Revenue (B USD) and Growth Rate (2013-2025) 45
  • Figure North America Transdermal Drug Delivery System Revenue (M USD) and Growth Rate (2012-2017) 46
  • Figure North America Insulin Pen Needles Revenue (M USD) and Growth Rate (2012-2022) 46
  • Figure China Microneedle Drug Delivery Systems Revenue (M USD) and Growth Rate (2020-2035) 47
  • Figure China Biologics and Biosimilars Revenue (B USD) and Growth Rate (2013-2025) 48
  • Figure China Transdermal Drug Delivery System Revenue (M USD) and Growth Rate (2012-2017) 48
  • Figure China Insulin Pen Needles Revenue (M USD) and Growth Rate (2012-2022) 49
  • Figure Europe Microneedle Drug Delivery Systems Revenue (M USD) and Growth Rate (2020-2035) 50
  • Figure Europe Biologics and Biosimilars Revenue (B USD) and Growth Rate (2013-2025) 51
  • Figure Europe Transdermal Drug Delivery System Revenue (M USD) and Growth Rate (2012-2017) 52
  • Figure Europe Insulin Pen Needles Revenue (M USD) and Growth Rate (2012-2022) 52
  • Figure Southeast Asia Microneedle Drug Delivery Systems Revenue (M USD) and Growth Rate (2020-2035) 53
  • Figure Southeast Asia Biologics and Biosimilars Revenue (B USD) and Growth Rate (2013-2025) 54
  • Figure Southeast Asia Transdermal Drug Delivery System Revenue (M USD) and Growth Rate (2012-2017) 54
  • Figure Southeast Asia Insulin Pen Needles Revenue (M USD) and Growth Rate (2012-2022) 55
  • Figure Japan Microneedle Drug Delivery Systems Revenue (M USD) and Growth Rate (2020-2035) 56
  • Figure Japan Biologics and Biosimilars Revenue (B USD) and Growth Rate (2013-2025) 57
  • Figure Japan Transdermal Drug Delivery System Revenue (M USD) and Growth Rate (2012-2017) 57
  • Figure Japan Insulin Pen Needles Revenue (M USD) and Growth Rate (2012-2022) 58
  • Figure India Microneedle Drug Delivery Systems Revenue (M USD) and Growth Rate (2020-2035) 59
  • Figure India Biologics and Biosimilars Revenue (B USD) and Growth Rate (2013-2025) 60
  • Figure India Transdermal Drug Delivery System Revenue (M USD) and Growth Rate (2012-2017) 60
  • Figure India Insulin Pen Needles Revenue (M USD) and Growth Rate (2012-2022) 61
  • Figure Global Microneedle Drug Delivery Systems Market Size (M USD) Comparison by Applications (2020-2035) 64
  • Table 3 M Company Profile 69
  • Figure Microneedle Drug Delivery Systems Product Picture of 3 M 70
  • Table Zosano Pharma Company Profile 70
  • Figure Microneedle Drug Delivery Systems Product Picture of Zosano Pharma 71
  • Table Becton-Dickinson (BD)Technologies Company Profile 72
  • Figure Microneedle Drug Delivery Systems Product Picture of Becton-Dickinson (BD)Technologies 73
  • Table Nanopass Technologies Company Profile 73
  • Table Corium Company Profile 75
  • Figure Microneedle Drug Delivery Systems Product Picture of Corium 76
  • Table Valeritas Company Profile 76
  • Figure Microneedle Drug Delivery Systems Product Picture of Valeritas 78
  • Table Nitto Company Profile 78
  • Figure Microneedle Drug Delivery Systems Product Picture of Nitto 79
  • Table Microdermics Company Profile 80
  • Figure Microneedle Drug Delivery Systems Product Picture of Microdermics 81
  • Table TheraJect, Inc Company Profile 81
  • Table Vaxxas Company Profile 83
  • Table Lohmann Therapie-Systeme AG Company Profile 84
  • Figure Microneedle Drug Delivery Systems Product Picture of Lohmann Therapie-Systeme AG 86
  • Figure Global 2020-2035 Microneedle Drug Delivery Systems Market Size (M USD) and Growth Rate Forecast 87
  • Figure North America 2020-2035 Microneedle Drug Delivery Systems Market Size (M USD) and Growth Rate Forecast 88
  • Figure China 2020-2035 Microneedle Drug Delivery Systems Market Size (M USD) and Growth Rate Forecast 89
  • Figure Europe 2020-2035 Microneedle Drug Delivery Systems Market Size (M USD) and Growth Rate Forecast 90
  • Figure Southeast Asia 2020-2035 Microneedle Drug Delivery Systems Market Size (M USD) and Growth Rate Forecast 91
  • Figure Japan 2020-2035 Microneedle Drug Delivery Systems Market Size (M USD) and Growth Rate Forecast 92
  • Figure India 2020-2035 Microneedle Drug Delivery Systems Market Size (M USD) and Growth Rate Forecast 93
  • Table Global Sales Market Size (M USD) of Microneedle Drug Delivery Systems by Type (2020-2026) 93
  • Table Global Sales Market Size (M USD) of Microneedle Drug Delivery Systems by Type (2026-2032) 94
  • Table Global Sales Market Size (M USD) of Microneedle Drug Delivery Systems by Type (2032-2035) 94
  • Table Global Market Size (M USD) of Microneedle Drug Delivery Systems by Application (2020-2026) 94
  • Table Global Market Size (M USD) of Microneedle Drug Delivery Systems by Application (2026-2032) 94
  • Table Global Market Size (M USD) of Microneedle Drug Delivery Systems by Application (2032-2035) 95

Top 20 Countries Highest Incidence of Colorectal Cancer in 2016 97

Top 20 Countries Highest Incidence of Lung Cancer in 2016 98

  • Figure Percent of New Cases by Age Group: Lung Cancer 99
  • Figure Percent of Deaths by Age Group: Lung Cancer 99

Top 20 Countries Highest Incidence of Pancreatic Cancer in 2016 101

Top 20 Countries Highest Incidence of Breast Cancer in 2016 102

  • Figure Percent of New Cases by Age Group: Prostate Cancer 104
  • Figure Percent of Deaths by Age Group: Prostate Cancer 104
  • Figure Estimated Prostate Cancer Incidence Worldwide in 2016 105

Information about World Cancer Statistics for the Most Common Cancers (excluding non-melanoma Skin Cancer) in 2016 105

  • Figure United States GDP per Capita 107
  • Figure Germany GDP per Capita 107
  • Figure United Kingdom GDP per Capita 108
  • Figure China GDP per Capita 108
  • Figure Japan GDP per Capita 109
  • Figure Price Trend of Crude Oil (USD/BBL) 109
  • Figure Price Trend of Brent Crude Oil (USD/BBL) 110
  • Figure Price Trend of Natural Gas (MMBtu) 110
  • Figure Price Trend of Gasoline (GAL) 111
  • Figure Price Trend of Copper (USD/LB) 111
  • Figure Price Trend of Steel (Yuan/MT) 112
  • Figure Price Trend of Aluminum (USD/MT) 112
  • Figure Price Trend of Iron Ore (USD/MT) 113
  • Figure USA Labor Cost Analysis 2015-2018 114
  • Figure Cost of Employing a Factory Worker 115
  • Figure Europe Labor Cost Analysis 2015-2018 116
  • Figure Germany Labor Cost Analysis 2015-2018 116
  • Figure UK Labor Cost Analysis 2015-2018 117
  • Figure France Labor Cost Analysis 2015-2018 117
  • Figure Italy Labor Cost Analysis 2015-2018 118
  • Figure Monthly Minimum Wages in Asia 2016 118
  • Figure China Labor Costs 2015-2018 119
  • Figure Japan Average Monthly Wages 2015-2018 119
  • Figure Global Electricity Prices by Select Countries in 2017 (in U.S. Dollars per Kilowatt Hour) 120
  • Table Average Price of Electricity to Ultimate Customers 2007-2018 121
  • Figure Electricity Prices for Household Consumers in 2017 122
  • Table China Cost of Electricity 2017 (PER KWH) 123
  • Table Research Programs/Design for This Report 126
  • Figure Bottom-up and Top-down Approaches for This Report 128
  • Figure Data Triangulation 129
  • Table Key Data Information from Secondary Sources 130
  • Table Key Data Information from Primary Sources 131

This report studies the global Microneedle Drug Delivery Systems market status and forecast, categorizes the global Microneedle Drug Delivery Systems market size by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, China, Japan, Southeast Asia, India and ROW.

Intradermal drug delivery is increasingly recognized as a potential solution to many of the challenges faced by new and existing medicines. Intradermal dosing provides the opportunity to more effectively administer agents such as small molecules, biologics, and vaccines, allowing for improved bioavailability. Nonetheless, the widespread use of this route of administration continues to be limited by technical challenges in the performing of intradermal injections, which requires specialized training and has poor reproducibility.

Microneedles are a rapidly growing technology developed to solve issues surrounding intradermal drug administration. While many microneedle platforms have been developed over nearly 2 decades, the issues and concerns remain largely the same.

In the following years, global market of Microneedle Drug Delivery Systems will develop rapidly, with an average growth rate of 55% during 2021 to 2035. In 2035, global revenue of Microneedle Drug Delivery Systems is nearly 1294 M USD.

The major players in global Microneedle Drug Delivery Systems market include

3 M

Zosano Pharma

Becton-Dickinson(BD)Technologies

Nanopass Technologies

Corium

Valeritas

Nitto

Microdermics

TheraJect, Inc

Vaxxas

Lohmann Therapie-Systeme AG

Geographically, this report is segmented into several key regions, with market size, market share and growth rate of Microneedle Drug Delivery Systems in these regions, from 2020 to 2035 (forecast), covering

North America

Europe

China

Japan

Southeast Asia

India

ROW

On the basis of product, the Microneedle Drug Delivery Systems market is primarily split into

Hollow Microneedle Technology

Solid Microneedle Technology

Dissolving Microneedles Technology

On the basis on the end users/applications, this report covers

Drug Delivery

Vaccine Delivery

Other

Table of Contents

1 Industry Overview of Microneedle Drug Delivery Systems 1

  • 1.1 Definition of Microneedle Drug Delivery Systems 1
  • 1.2 Microneedle Drug Delivery Systems Segment by Types 2
    • 1.2.1 Global Microneedle Drug Delivery Systems Market Size and Growth Rate Comparison by Types (2020-2035) 2
    • 1.2.2 Global Microneedle Drug Delivery Systems Market Size Share by Types in 2025 3
    • 1.2.3 Hollow Microneedle Technology 4
    • 1.2.4 Solid Microneedle Technology 4
    • 1.2.5 Dissolving Microneedles Technology 5
  • 1.3 Global Microneedle Drug Delivery Systems Segment by Applications 6
    • 1.3.1 Global Microneedle Drug Delivery Systems Consumption Comparison by Applications (2020-2035) 6
    • 1.3.2 Drug Delivery 7
    • 1.3.3 Vaccine Delivery 8
    • 1.3.4 Others 8
  • 1.4 Global Microneedle Drug Delivery Systems Market by Regions 9
    • 1.4.1 Global Microneedle Drug Delivery Systems Market Size and Growth Rate Comparison by Regions (2020-2035) 9
    • 1.4.2 North America Microneedle Drug Delivery Systems Status and Prospect (2020-2035) 10
    • 1.4.3 China Microneedle Drug Delivery Systems Status and Prospect (2020-2035) 11
    • 1.4.4 Europe Microneedle Drug Delivery Systems Status and Prospect (2020-2035) 12
    • 1.4.5 Japan Microneedle Drug Delivery Systems Status and Prospect (2020-2035) 13
    • 1.4.6 India Microneedle Drug Delivery Systems Status and Prospect (2020-2035) 14
    • 1.4.7 Southeast Asia Microneedle Drug Delivery Systems Status and Prospect (2020-2035) 15
  • 1.5 Global Microneedle Drug Delivery Systems Market Size 16
  • 1.6 Macroscopic Indicator 17
    • 1.6.1 GDP for Major Regions 17
    • 1.6.2 Interest Rate for Major Regions 19
    • 1.6.3 Population and Labor Considered for Forecast 23
    • 1.6.4 Disposable Income Considered for Forecast 24
    • 1.6.5 Price of Raw Materials in Dollars: Evolution 25

2 Manufacturing Cost Structure Analysis of Microneedle Drug Delivery Systems 26

  • 2.1 Raw Material and Suppliers 26
  • 2.2 Manufacturing Cost Structure Analysis of Microneedle Drug Delivery Systems 27
  • 2.3 Manufacturing Process Analysis of Microneedle Drug Delivery Systems 28
  • 2.4 Industry Chain Structure of Microneedle Drug Delivery Systems 29

3 Technical Data and Manufacturing Plants Analysis of Microneedle Drug Delivery Systems 30

  • 3.1 Headquarters and Established Date of Global Microneedle Drug Delivery Systems Major Manufacturers 30
  • 3.2 Product Type of Global Microneedle Drug Delivery Systems Major Manufacturers 30
  • 3.3 Clinical Stage of Global Microneedle Drug Delivery Systems Major Manufacturers 31

4 Global Microneedle Drug Delivery Systems Overall Market 32

  • 4.1 Product of 3M 32
    • 4.1.1 Solid Microneedle System (sMTS) 32
    • 4.1.2 Hollow Microneedle System (hMTS) 33
  • 4.2 Qtrypta 34
  • 4.3 Soluvia Microinjection System 35
  • 4.4 MicronJet600 35
  • 4.5 MicroCor 37
  • 4.6 h-Patch 38
  • 4.7 PASSPORT Transdermal Microporation Technology 38
  • 4.8 Products of Microdermics 39
  • 4.9 VaxMAT and DrugMAT 40
  • 4.10 Nanopatch 41
  • 4.11 Product of LTS 43

5 Microneedle Drug Delivery Systems Regional Market Analysis 44

  • 5.1 North America Microneedle Drug Delivery Systems Market Analysis 44
    • 5.1.1 North America Microneedle Drug Delivery Systems Market Overview 44
    • 5.1.2 North America Microneedle Drug Delivery Systems Potential Market Status 45
  • 5.2 China Microneedle Drug Delivery Systems Market Analysis 47
    • 5.2.1 China Microneedle Drug Delivery Systems Market Overview 47
    • 5.2.2 China 2013-2018E Microneedle Drug Delivery Systems Potential Market Status 48
  • 5.3 Europe Microneedle Drug Delivery Systems Market Analysis 50
    • 5.3.1 Europe Microneedle Drug Delivery Systems Market Overview 50
    • 5.3.2 Europe Microneedle Drug Delivery Systems Potential Market Status 51
  • 5.4 Southeast Asia Microneedle Drug Delivery Systems Market Analysis 53
    • 5.4.1 Southeast Asia Microneedle Drug Delivery Systems Market Overview 53
    • 5.4.2 Southeast Asia Microneedle Drug Delivery Systems Potential Market Status 54
  • 5.5 Japan Microneedle Drug Delivery Systems Market Analysis 56
    • 5.5.1 Japan Microneedle Drug Delivery Systems Market Overview 56
    • 5.5.2 Japan Europe Microneedle Drug Delivery Systems Potential Market Status 57
  • 5.6 India Microneedle Drug Delivery Systems Market Analysis 59
    • 5.6.1 India Microneedle Drug Delivery Systems Market Overview 59
    • 5.6.2 India Europe Microneedle Drug Delivery Systems Potential Market Status 60

6 Global Microneedle Drug Delivery Systems Segment Market Analysis (by Type) 62

  • 6.1 Hollow Microneedle Technology 62
  • 6.2 Solid Microneedle Technology 62
  • 6.3 Dissolving Microneedles Technology 63

7 Global Microneedle Drug Delivery Systems Segment Market Analysis (by Application) 64

  • 7.1 Global Microneedle Drug Delivery Systems Consumption by Application 64
  • 7.2 Different Application Microneedle Drug Delivery Systems Product Research Status 65
    • 7.2.1 Research in Drug Delivery Application 65
    • 7.3.2 Research in Vaccine Delivery Application 66
    • 7.3.3 Research in other Application 67

8 Analysis of Microneedle Drug Delivery Systems Industry Key Manufacturers 69

  • 8.1 3 M 69
    • 8.1.1 Company Profile 69
    • 8.1.2 Product Information 70
  • 8.2 Zosano Pharma 70
    • 8.2.1 Company Profile 70
    • 8.2.2 Product Information 71
  • 8.3 Becton-Dickinson (BD)Technologies 72
    • 8.3.1 Company Profile 72
    • 8.3.2 Product Information 73
  • 8.4 Nanopass Technologies 73
    • 8.4.1 Company Profile 73
    • 8.4.2 Product Information 74
  • 8.5 Corium 75
    • 8.5.1 Company Profile 75
    • 8.5.2 Product Information 76
  • 8.6 Valeritas 76
    • 8.6.1 Company Profile 76
    • 8.6.2 Product Information 78
  • 8.7 Nitto 78
    • 8.7.1 Company Profile 78
    • 8.7.2 Product Information 79
  • 8.8 Microdermics 80
    • 8.8.1 Company Profile 80
    • 8.8.2 Product Information 81
  • 8.9 TheraJect, Inc 81
    • 8.9.1 Company Profile 81
    • 8.9.2 Product Information 82
  • 8.10 Vaxxas 83
    • 8.10.1 Company Profile 83
    • 8.10.2 Product Information 84
  • 8.11 Lohmann Therapie-Systeme AG 84
    • 8.11.1 Company Profile 84
    • 8.11.2 Product Information 86

9 Development Trend of Analysis of Microneedle Drug Delivery Systems Market 87

  • 9.1 Global Microneedle Drug Delivery Systems Market Trend Analysis 87
  • 9.2 Microneedle Drug Delivery Systems Regional Market Trend 88
    • 9.2.1 North America 2020-2035 Microneedle Drug Delivery Systems Consumption Forecast 88
    • 9.2.2 China 2020-2035 Microneedle Drug Delivery Systems Consumption Forecast 89
    • 9.2.3 Europe 2020-2035 Microneedle Drug Delivery Systems Consumption Forecast 90
    • 9.2.4 Southeast Asia 2020-2035 Microneedle Drug Delivery Systems Consumption Forecast 91
    • 9.2.5 Japan 2020-2035 Microneedle Drug Delivery Systems Consumption Forecast 92
    • 9.2.6 India 2020-2035 Microneedle Drug Delivery Systems Consumption Forecast 93
  • 9.3 Microneedle Drug Delivery Systems Market Trend (Product Type) 93
  • 9.4 Microneedle Drug Delivery Systems Market Trend (Application) 94

10 Major Cancer Analysis 96

  • 10.1 Colorectal Cancer 96
    • 10.1.1 Colorectal Cancer Introduction 96
    • 10.1.2 Introduction of the Number of Patients with Colorectal Cancer 96
  • 10.2 Lung Cancer 97
    • 10.2.1 Lung Cancer Introduction 97
    • 10.2.2 Introduction of the Number of Patients with Lung Cancer 98
  • 10.3 Pancreatic Cancer 100
    • 10.3.1 Pancreatic Cancer Introduction 100
    • 10.3.2 Introduction of the Number of Patients with Pancreatic Cancer 100
  • 10.4 Breast Cancer 101
    • 10.4.1 Breast Cancer Introduction 101
    • 10.4.2 Introduction of the Number of Patients with Breast Cancer 102
  • 10.5 Prostate Cancer 103
    • 10.5.1 Prostate Cancer Introduction 103
    • 10.5.2 Introduction of the Number of Patients with Prostate Cancer 103
  • 10.6 Other Cancer 105

11 Factors Influencing 107

  • 11.1 Macro-Economic Factors 107
  • 11.2 Price Trend of Key Industrial Raw Material 109
    • 11.2.1 Oil & Gas 109
    • 11.2.2 Mineral and Metal 111
  • 11.3 Proportion of Manufacturing Cost Structure 113
    • 11.3.1 Raw Materials 113
    • 11.3.2 Labor Cost 113
    • 11.3.3 Other Costs Analysis 120
    • 11.3.4 Manufacturing Expenses 124

12 Conclusion of the Global Microneedle Drug Delivery Systems Market Professional Survey Report 2018 125

13 Methodology and Data Source 126

  • 13.1 Methodology/Research Approach 126
    • 13.1.1 Research Programs/Design 126
    • 13.1.2 Market Size Estimation 127
    • 13.1.3 Market Breakdown and Data Triangulation 128
  • 13.2 Data Source 129
    • 13.2.1 Secondary Sources 129
    • 13.2.2 Primary Sources 130
  • 13.3 Unit Considered and Currency 131
  • 13.4 Author List 133
  • 13.5 Disclaimer 133
Back to Top
전화 문의
이용안내
 
BCC Research